Ocular Hypertension Completed Phase 3 Trials for Brimonidine (DB00484)

Also known as: Hypertension Ocular / Intraocular pressure high / Intraocular hypertension / Intraocular pressure raised / Ocular Hypertension (OHT) / Ocular Hypertension (OH) / Hypertension, Ocular / Elevated Intraocular Pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03257813Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)Treatment
NCT02339584Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)Treatment
NCT00652483Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular HypertensionTreatment
NCT00652106Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionTreatment
NCT01216943Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular HypertensionTreatment
NCT01217606Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01241240Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01297517Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%Treatment
NCT01297920Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%Treatment
NCT01309204Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionTreatment
NCT01310777Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionTreatment
NCT00651612Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension PatientsTreatment
NCT00061529A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00332436Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionTreatment
NCT00332384Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionTreatment
NCT00168363Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular HypertensionTreatment